IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal

Hypoglycemia is a rare paraneoplastic manifestation of patients with neoplasms. Hypoglycemia can be induced by several causes, including an aberrant increase of hypoglycemic agents and adrenal insufficiency. Sorafenib is the first agent to demonstrate a survival benefit in the treatment of advanced...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Okushin, Kazuya, Asaoka, Yoshinari, Fukuda, Izumi, Fujiwara, Naoto, Minami, Tatsuya, Sato, Masaya, Mikami, Shintaro, Uchino, Koji, Enooku, Kenichiro, Kondo, Yuji, Tateishi, Ryosuke, Goto, Tadashi, Shiina, Shuichiro, Yoshida, Haruhiko, Koike, Kazuhiko
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2012
Témata:
Published online: December, 2012
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551420/
https://ncbi.nlm.nih.gov/pubmed/23341802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000346462
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky